Vivitrol's Opioid Abuse Claim Will Likely Need Monitoring and Support Services
• By The Pink Sheet Daily
FDA's Psychopharmacologic Drugs Advisory Committee voted in favor of expanding the indication for Alkermes' alcoholism treatment by lopsided margins, with the caveat that monitoring and support must be provided to patients.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
